The AJMC® Diabetes compendium is a comprehensive resource for clinical news and expert insights for the chronic condition.
December 10th 2025
Many US patients with diabetes cannot afford their medical care. The authors review the impact of interventions that reduced and/or eliminated diabetes-related costs.
The Economics of Transthyretin-Mediated Amyloidosis: Balancing Equity and Access in Resource Allocation
1 Credit / Cardiology, Neurology
View More
Advancing Immunotherapy in Endometrial Cancer: A Managed Care Perspective on Personalized Care
1.5 Credits / Gynecologic Cancer, Health Equity, Diversity & Inclusion, Oncology, Women's Health
View More
Legislation Aims to Protect Chronically Ill
January 17th 2014Patients at high risk - including those with cancer, diabetes, and cardiovascular disease - will be covered under the Pre-Existing Condition Insurance Plan (PCIP) until March 31, thanks to a decision this week from the Department of Health and Human Services.
Read More
Comorbidities and Cardiovascular Disease Risk in Older Breast Cancer Survivors
Effective management of the comorbidities of diabetes and hypertension may increase survival in older breast cancer survivors.
Read More
Process of Care Compliance Is Associated With Fewer Diabetes Complications
Adherence to process of care measures was associated with reduced risk of 2 diabetes complications or any of 4 complications in a national industrial cohort.
Read More
What Endocrinologists Can Expect From Obamacare
December 30th 2013Healthcare reform is already presenting new challenges and opportunities for endocrinology, a specialty that is under significant stress in the United States. A critical workforce shortage has drained the pool of practicing endocrinologists, just as the Affordable Care Act (ACA) is expected to send millions of newly insured people into the system.
Read More
As NYC's Big Soda Ban Awaits de Blasio, Science Firmly on the Side of Smaller Portions
December 23rd 2013This month's edition of Evidence-Based Diabetes Management, a news source of The American Journal of Managed Care, examines the science behind Mayor Michael Bloomberg's pursuit of soda portion limits, as well as alternatives for curtailing consumption to fight obesity. Soon after Mayor-elect de Blasio takes office, he must decide how to achieve Bloomberg's goal, including whether to continue litigation before the New York State Court of Appeals.
Read More
HTN Guidelines Loosen BP Cutoffs
December 18th 2013The long-awaited update to guidelines for the management of hypertension - from the panel appointed to the Eighth Joint National Committee (JNC 8) - raises the recommended blood pressure threshold to determine the need for drug therapy in many patients.
Read More
NOW AVAILABLE: A Special Report on Diabetes Innovation 2013
December 17th 2013To build on the success and ideas generated at last year's inaugural event, Joslin Diabetes Center once again brought together numerous key stakeholders in the collective battle to conquer diabetes and to provoke thought, innovation, and action. Highlights from Diabetes Innovation, which took place on October 3-5, 2013, in Washington, DC, are available in a special report published by The American Journal of Managed Care.
Read More
High-Risk Consumers Get Needed Coverage Extension
December 17th 2013In an effort to avoid a coverage gap in health insurance, those covered under the Pre-existing Condition Insurance Plan (PCIP) will get until January 2014 to enroll into a new plan through the state or federal healthcare exchange website.
Read More
Patients With Diabetes Who Use Mail Order Pharmacy Are Less Likely to Visit Emergency Rooms
November 22nd 2013Patients with diabetes who received prescribed heart medications by mail were less likely to visit the emergency room than those who picked up prescriptions in person, according to a new Kaiser Permanente study published in the American Journal of Managed Care.
Read More
Safety and Effectiveness of Mail Order Pharmacy Use in Diabetes
Patients using mail order pharmacies have lower healthcare utilization, but somewhat less laboratory monitoring of persistent medications and slightly higher contraindicated medication use.
Read More
Which Models Will Improve Patient Outcomes?
November 8th 2013Whereas population health focuses on the outcomes within a specific group, personalized medicine seeks to customize care delivery at the individual level. A recent discussion between Dr Eric Topol, director, Scripps Translational Science Institute, and Dr Farzad Mostashari, former director of the Office of the National Coordinator for Health Information Technology, highlighted the diverging opinions of where future healthcare models need to go.
Read More
Dispensing Channel and Medication Adherence: Evidence Across 3 Therapy Classes
Findings indicate that patients using mail order pharmacies had significantly better adherence to antidiabetics, antihypertensives, and antihyperlipidemics than patients who used the retail dispensing channel.
Read More
Curtis Triplitt, PharmD, on Patient-Centered Diabetes Care
October 17th 2013In this interview, Curtis Triplitt, PharmD, associate professor and assistant dean of research, Texas Tech University Health Sciences Center, Permian Basin, explains why diabetes should be treated with a patient-centered approach.
Read More
Health Benefits of Restorative Yoga Include Trimming Fat, NIH-Funded Study Finds
October 16th 2013Yoga's stress-reduction benefits are well-known. Now, a study funded by NIH finds that restorative yoga burns subcutaneous fat in overweight women. The study may point to a practical way for the obese to ease into exercise.
Read More
With MiniMed 530G, Medtronic Seeks New CMS Code
October 1st 2013With the unveiling of the first FDA-approved system with the name "artificial pancreas," Medtronic will seek a new CMS code that would cover both the insulin pump and the continuous glucose monitoring parts of the process, according to the company.
Read More
With speculation about an artificial pancreas rising, the September edition of Evidenced-Based Diabetes Management looked at the three systems that were being considered by the FDA including the threshold suspend technology Medtronic announced Friday and asked the next questions: Assuming the technology is approved, will insurers pay for it? How will this potentially life-altering advance make its way into the hands of the persons with diabetes who need it most?
Read More
Improving Patient-Centered Care in Diabetes With Comparative Effectiveness Research
Read More